NPS Pharma (NPSP) Reports Q3 Loss of $0.16, Misses by 4c
More News related to NPSP
- NPS Pharma (NPSP) Reports Q3 Loss of $0.16, Misses by 4c
- NPS Pharmaceuticals Reports Third Quarter Results and Improved Cash Burn Guidance
- Trading Radar for 11/04: Cisco (CSCO), Comcast (CMCSA), Tyco (TEL), Molson Coors (TAP) Report
- NPS Pharmaceuticals to Report Third Quarter Financial Results on November 4, 2009
- Data Demonstrate That GATTEX(TM) (Teduglutide) Improves Lean Body Mass, Mineral Composition and Electrolyte Levels in Patients with Parenteral Nutrition Dependent Short Bowel Syndrome
More News related to Earnings
- Highlights From DE's Q4 Conference Call: Production Will Pick Up in 2010, But Overall Conditions to Remain Fairly Restrained
- Highlights From TIF's Q3 Conference Call: Sales Declines, But Less-Than-Expected; Raises FY Outlook
- Highlights From JCG's Q3 Conference Call: Comp Store Sales and Revenues Were Up; Guides In-line for Q4
- Deere (DE) Q4 Sales Fall, But Results Beat Analysts Views
- Tiffany (TIF) Shines In Q3
NPS Pharmaceuticals (NASDAQ: NPSP) reports Q3 loss of $0.16, 4 cents worse than the analyst estimate of ($0.12).
Related Categories
EarningsStocks Mentioned
+0.02Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
